Savage Brian: insider trades.
Savage Brian reported 4 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($285K), across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 3
- Companies
- 1
- Name as filed
- Savage Brian
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Teva Pharmaceutical Industries Ltd (TEVA) | Officer · Interim Chief Legal Officer | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-18 | Teva Pharmaceutical Industries Ltd | S | 314 | $38.7 | 8,500 | Form 4 |
| 2026-09-18 | Teva Pharmaceutical Industries Ltd | S | 2,525 | $39.15 | 8,814 | Form 4 |
| 2026-09-18 | Teva Pharmaceutical Industries Ltd | S | 4,503 | $38.69 | 11,339 | Form 4 |
| 2026-09-18 | Teva Pharmaceutical Industries Ltd | M | 4,503 | $34.7 | 15,842 | Form 4 |
Questions
What stock did Savage Brian buy or sell?
Savage Brian reported 4 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($285K), across 1 company.
Is Savage Brian the same person as other filers with this name?
This page covers SEC CIK 2112339 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/savage-brian-2112339.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.